TrialBMC endocrine disorders2020

The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.

Rosemary Dineen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.